PMID: 1233211Feb 28, 1975Paper

The measurement of drug consumption. Drugs for diabetes in Northern Ireland, Norway and Sweden

European Journal of Clinical Pharmacology
U BergmanB Westerholm

Abstract

The consumption of insulin and oral antidiabetic drugs was measured at the gross sales level in Sweden and Norway and at the prescription level in Northern Ireland. "Agreed daily doses'' were used as units of comparison, which defined as follows: insulin 40 I.U., tolbutamide 1 g, acetohexamide 500 mg etc. Consumption was expressed as the number of "agreed daily doses'' per 1,000 inhabitants per day. This provided a rough estimate of the number of subjects for whom the drug had been prescribed per 1,000 population. The data were collected during the three months April-June 1971. Marked differences in the consumption of antidiabetic drugs were found between the three countries and also between areas within each country. The consumption of insulin was similar in Norway and Northern Ireland (3.5 and 3.9 agreed daily doses per 1,000 inhabitants per day), but almost twice as high in Sweden. In Norway much lower use was found in certain rural areas. The variation in the consumption of oral antidiabetic drugs was even more marked. Surprisingly, consumption was considerably higher in Sweden (15.8) than in the nearby Norway (7.3), and was even lower in Northern Ireland (4.3). The major use was of sulphonylureas, especially chlorpropamide...Continue Reading

References

Feb 12, 1972·Lancet·D BoyleJ A Weaver
Sep 10, 1966·British Medical Journal·O L Wade, G D McDevitt

❮ Previous
Next ❯

Citations

Nov 1, 1979·European Journal of Clinical Pharmacology·F AndreasenM Nielsen
Jan 1, 1992·European Journal of Clinical Pharmacology·R A KiivetF Sjöqvist
Jan 1, 1992·British Journal of Clinical Pharmacology·J HallasK B Jensen
May 1, 1986·Acta Psychiatrica Scandinavica·C Allgulander
Jan 20, 1998·Clinical Pharmacology and Therapeutics·C L DeckersW O Renier
Nov 15, 2018·Proceedings of the National Academy of Sciences of the United States of America·Eili Y KleinRamanan Laxminarayan
Jul 1, 1979·European Journal of Clinical Pharmacology·T KorhonenA Aro
Jan 1, 1992·European Journal of Clinical Pharmacology·J BenítezJ A Díaz
Jul 17, 1999·Medical Care·C MetgeA L Kozyrskyj
Dec 6, 2005·Pharmacoepidemiology and Drug Safety·Ulf Bergman
Dec 8, 2004·European Journal of Clinical Pharmacology·Emilio J Sanz
May 10, 2013·European Journal of Clinical Pharmacology·Björn Wettermark
Jan 1, 1980·European Journal of Clinical Pharmacology·U BergmanB E Wiholm
Jan 1, 1990·European Journal of Clinical Pharmacology·A Wessling, G Boëthius
Jan 1, 1984·European Journal of Clinical Pharmacology·M StanulovićN Roncević
Jun 1, 1983·Journal of Clinical and Hospital Pharmacy·K Griffiths, D G McDevitt
Dec 8, 2009·Basic & Clinical Pharmacology & Toxicology·Kari FuruHenrik Toft Sørensen
May 25, 2013·Pharmacoepidemiology and Drug Safety·B WettermarkHt Sørensen
Oct 22, 2015·Pharmacoepidemiology and Drug Safety·Carlos E DuránRobert Vander Stichele
Jul 1, 1989·Medical Toxicology and Adverse Drug Experience·L L GustafssonR Stig
Jan 1, 1984·Acta Medica Scandinavica. Supplementum·U Bergman, F Sjöqvist
Aug 1, 1980·European Journal of Clinical Pharmacology·U Bergman Ostman

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.